We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Capillary and Venous Lactate Compared in ED Patients

By LabMedica International staff writers
Posted on 16 Apr 2019
Print article
Image: The Automatic QC RAPID Systems RAPIDPoint 500 blood gas analyzer (Photo courtesy of Siemens Healthcare).
Image: The Automatic QC RAPID Systems RAPIDPoint 500 blood gas analyzer (Photo courtesy of Siemens Healthcare).
Elevated lactate levels are a common finding in acutely unwell patients. Blood lactate level is a good predictor of patient outcome and high lactate levels are associated with high morbidity and mortality. Lactate may be detected and measured in all blood samples: arterial, venous and capillary.

Currently, blood lactate can be measured formally in the laboratory, using blood gas analyzers or with handheld devices. Strong correlations have been shown between blood lactate levels in samples analyzed in the central laboratory, by blood gas analyzers and handheld devices. Capillary blood lactate testing with handheld analyzers has great advantages to reduce the time needed for clinical decisions, and for extended use in the prehospital setting.

Emergency department (ED) personnel at the Chinese University of Hong Kong (Shatin, Hong Kong) and their colleagues carried out a prospective observational study of patients presenting to the ED of Prince of Wales Hospital (Shatin, Hong Kong) and 240 patients (mean age 69.9 years) were recruited. Venous and capillary blood samples were collected for lactate analysis. Venous blood samples (approximate 1 mL) were collected by venipuncture while capillary blood samples were collected by finger-prick with a disposable lancet.

Venous lactate levels were measured by blood gas analyzer the Siemens Automatic QC RAPID Systems RAPIDPoint 500 (VL-Ref) served as the reference standard. Capillary lactate levels were immediately analyzed by two handheld lactate analyzers: Nova StatStrip Xpress Lactate Meter (CL-Nova) and Lactate Scout+ (CL-Scout). Venous lactate levels were also measured on the two handheld lactate analyzers. All lactate measurements were performed within 15 minutes after obtaining the venous sample.

The scientists reported that the results of VL-Ref ranged from 0.70 to 5.38 mmol/L (mean of 1.96 mmol/L). Regarding capillary lactate measurements, the bias (mean difference) between VL-Ref and CL-Scout+ was −0.22 with 95% limits of agreement (LOA) of −2.17 to 1.73 mmol/L and the bias between VL-Ref and CL-Nova was 0.46, with LOA of −1.08 to 2.00 mmol/L. For venous lactate, results showed the bias between VL-Ref and VL-Scout+ were 0.22 with LOA being −0.46 to 0.90 mmol/L, and the bias between VL-Ref and VL-Nova was 0.83 mmol/L with LOA −0.01 to 1.66 mmol/L.

The author concluded that their study shows poor agreement between capillary lactate and reference values. The study does not support the clinical utility of capillary lactate point-of-care testing (POCT). However, venous lactate measured by Scout+ handheld analyzer may have potential for screening patients who may need further testing. The study was published on April 3, 2019, in the journal BMJ OPEN.

Related Links:
Chinese University of Hong Kong
Prince of Wales Hospital

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more